Wright State University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Wright State University sits in the top decile of US sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count).

32 total trials 10 currently recruiting 13 completed early-phase tilt top decile by trial count

Wright State University: 32 sponsored US clinical trials, 10 recruiting.

Wright State University sponsors 32 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 13 completed. 6 of these trials are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 3 trials.

Top-decile sponsor footprint

Wright State University ranks in the top decile of sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 10/100

13 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (68.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

32 total, page 1 of 1

RECRUITING NA

Mechanisms for Laser-Induced Rejuvenation

NCT06489301

RECRUITING Phase 4

Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage

NCT07116408

RECRUITING NA

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

NCT06428721

RECRUITING Phase 2

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

NCT06312813

RECRUITING Phase 1

The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

NCT05688904

RECRUITING NA

DNA Repair Activity in the Skin of Day and Night Shift Workers

NCT04122456

RECRUITING Phase 1

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects

NCT04520217

RECRUITING Early Phase 1

Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

NCT04036188

RECRUITING Early Phase 1

Gene Expression Changes In Young and Geriatric Skin

NCT03932162

RECRUITING NA

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

NCT03906253

ACTIVE NOT RECRUITING Phase 1

Sphenopalatine Ganglion Block and Cold Induced Headaches

NCT06310200

NOT YET RECRUITING Phase 1

Pilot Studies Testing the Use of Oral Amitriptyline in Reducing Localized Burn Injury-induced Microvesicle Particle Release

NCT07640061

NOT YET RECRUITING NA

AI-Augmented Motivational Interviewing Training for Primary Care

NCT06597123

COMPLETED

The Validation of New Photographic Technology for Assessing Skin Lesions

NCT06663241

COMPLETED Phase 3

Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure

NCT05355974

COMPLETED Early Phase 1

Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli

NCT05287724

COMPLETED NA

"Up-Armoring" At-Risk Military Couples: A Stepped Approach to Early Intervention and Strengthening of Military Families

NCT06948877

COMPLETED

Pilot Studies Testing Levels of P63 in Psoriasis Skin Lesions

NCT04560647

TERMINATED Phase 4

Postpartum Management of Gestational Hypertensive Disorders Using Furosemide

NCT04343235

TERMINATED NA

Vaginal Prep Solutions to Reduce Bacteria Colony Counts in Patients Having a Vaginal Surgery

NCT03854370

COMPLETED NA

Post-partum Non-pharmacologic Pain Management

NCT03903172

TERMINATED Phase 1

Photodynamic Therapy-Induced Immune Modulation: Part III

NCT03643744

COMPLETED Phase 1

UVB-Induced MVP Release in Human Skin

NCT05734235

COMPLETED NA

Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction

NCT02865187

COMPLETED NA

Evaluation of a Brief Marriage Intervention for Internal Behavioral Health Consultants in Military Primary Care

NCT02571478

TERMINATED NA

Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement

NCT02628873

TERMINATED Phase 4

Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia

NCT02478710

COMPLETED Phase 2

Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation

NCT00906204

COMPLETED Phase 3

Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial

NCT01003496

TERMINATED Phase 4

Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study

NCT00944216

COMPLETED NA

Efficacy of the Individual Placement and Support (IPS) Model

NCT01048346

COMPLETED Phase 2

Reducing Barriers to Drug Abuse Treatment Services

NCT00273845

Phase Distribution

PhaseTrial count
Phase 1 9
Phase 2 3
Phase 3 2
Phase 4 4

What is open in the Wright State University pipeline

10 recruiting of 32 indexed (31% open); 13 completed (41%).

Phase mix: 6 late (III/IV) vs 12 early (I/II) (early-phase heavy).

Top condition: Aging (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Wright State University: open-pipeline peers nationwide

Peers matched on 32 registered trials and 31% open enrollment, not the therapeutic-area sidebar.

Wright State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1020304050 0%10%20%30%40% Total trials Recruiting share Wright State UniversityAerie PharmaceuticalsAllina Health SystemArdea BiosciencesHebrew SeniorLifeEko DevicesVarian, a Siemens Healthineers CompanyLaureate Institute for Brain ResearchPhilips Clinical & Medical Affairs Global
Wright State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Wright State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 32 trials (± recruiting share)

Sponsors near 31% open enrollment (± trial volume)

What to do with this Wright State University page

32 registered trials is a research-attention snapshot, not an endorsement of Wright State University or any single study.

  • 10 of Wright State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Aging is the condition Wright State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Wright State University pipeline card: 32 registered trials from official public datasets.Report a data error.